株探米国株
日本語 英語
エドガーで原本を確認する
SYNOPSYS INC false 0000883241 0000883241 2025-05-28 2025-05-28
 
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (date of earliest event reported): May 28, 2025

 

 

SYNOPSYS, INC.

(Exact name of registrant as specified in charter)

 

 

 

Delaware   000-19807   56-1546236

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

675 Almanor Ave.

Sunnyvale, California 94085

(Address of principal executive offices) (Zip code)

Registrant’s telephone number, including area code: (650) 584-5000

N/A

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading
Symbol(s)

 

Name of each exchange

on which registered

Common Stock
(par value of $0.01 per share)
  SNPS   Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 
 


Item 2.02

Results of Operations and Financial Condition.

On May 28, 2025, Synopsys, Inc. (“Synopsys”, “we”, “our”, or “us”) issued a press release announcing the financial results of its second fiscal quarter ended April 30, 2025. A copy of the press release is furnished and attached hereto as Exhibit 99.1 and is incorporated herein by reference.

The information in this Current Report on Form 8-K, including Exhibit 99.1 attached hereto and incorporated by reference herein, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended. The information contained herein and in the accompanying exhibit shall not be incorporated by reference into any registration statement or other document filed with the Securities and Exchange Commission by Synopsys whether made before or after the date hereof, regardless of any general incorporation language in such filing, except as shall be expressly set forth by specific reference in such filing.

 

Item 9.01

Financial Statements and Exhibits.

(d) Exhibits

 

Exhibit

Number

  

Exhibit Title

99.1    Press release dated May 28, 2025 containing Synopsys, Inc.’s results of operations for its second fiscal quarter ended April 30, 2025.
104    Cover Page Interactive Data File (embedded within the Inline XBRL document).


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

 

    SYNOPSYS, INC.
 Dated: May 28, 2025     By:  

/s/ John F. Runkel, Jr.

            John F. Runkel, Jr.
            General Counsel and Corporate Secretary
EX-99.1 2 d815632dex991.htm EX-99.1 EX-99.1

EXHIBIT 99.1

PRESS RELEASE

INVESTOR CONTACT:

Trey Campbell

Synopsys, Inc.

650-584-4289

Synopsys-ir@synopsys.com

EDITORIAL CONTACT:

Cara Walker

Synopsys, Inc.

650-584-5000

corp-pr@synopsys.com

Synopsys Posts Financial Results for Second Quarter Fiscal Year 2025

Results Summary

 

   

Quarterly revenue of $1.604 billion, exceeding midpoint of guidance.

 

   

Quarterly GAAP earnings per diluted share of $2.24; non-GAAP earnings per diluted share of $3.67, exceeding guidance.

 

   

Reaffirming full-year 2025 revenue guidance, and non-GAAP operating margin guidance.

SUNNYVALE, Calif. – May 28, 2025 – Synopsys, Inc. (Nasdaq: SNPS) today reported results for its second quarter of fiscal year 2025. Revenue for the second quarter of fiscal year 2025 was $1.604 billion, compared to $1.455 billion for the second quarter of fiscal year 2024.

“We delivered a strong quarter, which demonstrates the mission-critical nature of our products and the resiliency of our business,” said Sassine Ghazi, president and CEO of Synopsys. “The mega trends of AI, software-defined systems, and silicon proliferation continue to drive our growth. These trends are increasing design complexity and costs, while also increasing compute performance and energy demands. Synopsys is a trusted partner in addressing these challenges and a leader in applying AI to help customers innovate faster.”


“In a dynamic macro environment, Synopsys continues to execute with strong Q2 results on the top and bottom line,” said Shelagh Glaser, CFO of Synopsys. “We’re poised to deliver a solid second half, and we’re reaffirming our full-year revenue and operating margin guidance, reflecting our confidence in the business and continued healthy demand for our products.”

Continuing Operations

On September 30, 2024, Synopsys completed the sale of its Software Integrity business. Unless otherwise noted, Synopsys’ Software Integrity business has been presented as a discontinued operation in the Synopsys’ consolidated financial statements for all periods presented herein and all financial results and targets are presented herein on a continuing operations basis.

GAAP Results

On a U.S. generally accepted accounting principles (GAAP) basis, net income for the second quarter of fiscal year 2025 was $349.2 million, or $2.24 per diluted share, compared to $299.1 million, or $1.92 per diluted share, for the second quarter of fiscal year 2024.

Non-GAAP Results

On a non-GAAP basis, net income for the second quarter of fiscal year 2025 was $572.7 million, or $3.67 per diluted share, compared to non-GAAP net income of $466.9 million, or $3.00 per diluted share, for the second quarter of fiscal year 2024.

For a reconciliation of net income, earnings per diluted share and other measures on a GAAP and non-GAAP basis, see “GAAP to Non-GAAP Reconciliation” in the accompanying tables below.

Business Segments

Synopsys reports revenue and operating income in two segments: (1) Design Automation, which includes our advanced silicon design, verification products and services, system integration products and services, digital, custom and field programmable gate array IC design software, verification software and hardware products, manufacturing software products and other and (2) Design IP, which includes our interface, foundation, security, and embedded processor IP, IP subsystems, and IP implementation services.

 

2


Financial Targets

Synopsys also provided its consolidated financial targets for the third quarter and full fiscal year 2025. These targets reflect a change in Synopsys’ fiscal year from a 52/53-week period ending on the Saturday nearest to October 31 of each year to October 31 of each year. As a result of this change, there will be ten fewer days in the first half of fiscal year 2025 and two extra days in the second half of fiscal year 2025, which results in eight fewer days in the aggregate in Synopsys’ fiscal year 2025 as compared to its fiscal year 2024. These targets also assume no further changes to export control restrictions or the current U.S. government “Entity List” restrictions. These targets constitute forward-looking statements and are based on current expectations. For a discussion of factors that could cause actual results to differ materially from these targets, see “Forward-Looking Statements” below.

Third Quarter and Full Fiscal Year 2025 Financial Targets (1)

(in millions except per share amounts)

 

     Range for Three Months
Ending
July 31, 2025
    Range for Fiscal Year
Ending October 31, 2025
 
     Low     High     Low     High  

Revenue

   $ 1,755     $ 1,785      $ 6,745     $ 6,805  

GAAP Expenses

   $ 1,273     $ 1,293      $ 5,011     $ 5,068  

Non-GAAP Expenses

   $ 1,055     $ 1,065      $ 4,045     $  4,085  

Non-GAAP Interest and Other Income (Expense), net

   $ 9     $ 11      $ 118     $ 122  

Non-GAAP Tax Rate

     16     16     16     16

Outstanding Shares (fully diluted)

     156       158       156       158  

GAAP EPS

   $ 2.63     $ 2.74      $ 10.14     $ 10.34  

Non-GAAP EPS

   $ 3.82     $ 3.87      $ 15.11     $ 15.19  

Operating Cash Flow

       ~$ 1,500    

Free Cash Flow(2)

       ~$  1,300    

Capital Expenditures

       ~$ 170    

 

(1)

Targets do not reflect the impact of any future financing transactions related to the Ansys Merger (as defined below) or targets for the combined company.

(2)

Free cash flow is calculated as cash provided from operating activities less capital expenditures.

 

3


For a reconciliation of Synopsys’ third quarter and fiscal year 2025 targets, including expenses, earnings per diluted share and other measures on a GAAP and non-GAAP basis and a discussion of the financial targets that we are not able to reconcile without unreasonable efforts, see “GAAP to Non-GAAP Reconciliation” in the accompanying tables below.

Earnings Call Open to Investors

Synopsys will hold a conference call for financial analysts and investors today at 2:00 p.m. Pacific Time. A live webcast of the call will be available on Synopsys’ corporate website at www.investor.synopsys.com. Synopsys uses its website as a tool to disclose important information about Synopsys and comply with its disclosure obligations under Regulation Fair Disclosure. A webcast replay will also be available on the corporate website from approximately 5:30 p.m. Pacific Time today through the time Synopsys announces its results for the third quarter of fiscal year 2025.

Effectiveness of Information

The targets included in this press release, the statements made during the earnings conference call, the information contained in the financial supplement and the corporate overview presentation, each of which are available on Synopsys’ corporate website at www.synopsys.com (collectively, the “Earnings Materials”), represent Synopsys’ expectations and beliefs as of May 28, 2025. Although these Earnings Materials will remain available on Synopsys’ website through the date of the earnings call for the third quarter of fiscal year 2025, their continued availability through such date does not mean that Synopsys is reaffirming or confirming their continued validity. Synopsys undertakes no duty and does not intend to update any forward-looking statement, whether as a result of new information or future events, or otherwise update, the targets given in this press release unless required by law.

Availability of Final Financial Statements

Synopsys will include final financial statements for the second quarter of fiscal year 2025 in its quarterly report on Form 10-Q to be filed on or before June 9, 2025.

 

4


Reconciliation of Second Quarter Fiscal Year 2025 Results

The following tables reconcile the specific items excluded from GAAP in the calculation of non-GAAP net income, earnings per diluted share, and tax rate for the periods indicated below.

GAAP to Non-GAAP Reconciliation of Second Quarter Fiscal Year 2025 Results(1)

(unaudited and in thousands, except per share amounts)

 

     Three Months Ended
April 30,
     Six Months Ended
April 30,
 
     2025      2024      2025      2024  

GAAP net income from continuing operations attributed to Synopsys

   $ 349,232      $ 299,111      $ 644,915      $ 736,561  

Adjustments:

           

Amortization of acquired intangible assets

     11,656        16,925        24,252        32,526  

Stock-based compensation

     201,723        162,346        388,002        327,487  

Acquisition/divestiture related items

     69,514        25,256        144,343        57,188  

(Gain) loss on sale of strategic investments

     2,435        —         2,435        (55,077

Tax adjustments

     (61,862      (36,694      (158,076      (106,261
  

 

 

    

 

 

    

 

 

    

 

 

 

Non-GAAP net income from continuing operations attributed to Synopsys

   $ 572,698      $ 466,944      $ 1,045,871      $ 992,424  
  

 

 

    

 

 

    

 

 

    

 

 

 
     Three Months Ended
April 30,
     Six Months Ended
April 30,
 
     2025      2024      2025      2024  

GAAP net income from continuing operations per diluted share attributed to Synopsys

   $ 2.24      $ 1.92      $ 4.13      $ 4.73  

Adjustments:

           

Amortization of acquired intangible assets

     0.07        0.11        0.16        0.21  

Stock-based compensation

     1.29        1.04        2.48        2.10  

Acquisition/divestiture related items

     0.45        0.16        0.92        0.37  

(Gain) loss on sale of strategic investments

     0.02        —         0.02        (0.35

Tax adjustments

     (0.40      (0.23      (1.02      (0.68
  

 

 

    

 

 

    

 

 

    

 

 

 

Non-GAAP net income from continuing operations per diluted share attributed to Synopsys

   $ 3.67      $ 3.00      $ 6.69      $ 6.38  
  

 

 

    

 

 

    

 

 

    

 

 

 

Shares used in computing net income per diluted share amounts:

     156,088        155,770        156,218        155,610  

 

(1)

Synopsys’ second quarter of fiscal year 2025 and 2024 ended on April 30, 2025 and May 4, 2024, respectively. For presentation purposes, we refer to the closest calendar month end. Fiscal year 2024 was a 53-week year, which included an extra week in the first quarter.

 

5


GAAP to Non-GAAP Tax Rate Reconciliation (1)

(unaudited)

 

     Three Months Ended
April 30, 2025
    Six Months Ended
April 30, 2025
 

GAAP effective tax rate

     11.9     5.9

Stock-based compensation

     (0.5 )%      1.5

Acquisition/divestiture related items (2)

     0.9     5.4

Tax adjustments (3)

     3.7     3.2
  

 

 

   

 

 

 

Non-GAAP effective tax rate

     16.0     16.0
  

 

 

   

 

 

 

 

(1)

Presented on a continuing operations basis.

(2)

The adjustment is primarily due to the capital loss on the sale of Synopsys’ ownership in OpenLight Photonics, Inc.

(3)

The adjustments are primarily related to the differences in the tax rate effect of certain deductions, such as the deduction for foreign-derived intangible income and credits.

Reconciliation of 2025 Targets

The following tables reconcile the specific items excluded from GAAP in the calculation of non-GAAP targets for the periods indicated below.

GAAP to Non-GAAP Reconciliation of Third Quarter Fiscal Year 2025 Targets

(in thousands, except per share amounts)

 

     Range for Three Months Ending
July 31, 2025
 
     Low      High  

Target GAAP expenses

   $ 1,273,000      $ 1,293,000  

Adjustments:

     

Amortization of acquired intangible assets

     (11,000      (14,000

Stock-based compensation

     (207,000      (214,000
  

 

 

    

 

 

 

Target non-GAAP expenses

   $ 1,055,000      $ 1,065,000  
  

 

 

    

 

 

 

 

6


     Range for Three Months Ending
July 31, 2025
 
     Low      High  

Target GAAP earnings per diluted share attributed to Synopsys

   $ 2.63      $ 2.74  

Adjustments:

     

Amortization of acquired intangible assets

     0.09        0.07  

Stock-based compensation

     1.36        1.32  

Acquisition/divestiture related items (1)

     0.01        —   

Tax adjustments

     (0.27      (0.26
  

 

 

    

 

 

 

Target non-GAAP earnings per diluted share attributed to Synopsys

   $ 3.82      $ 3.87  
  

 

 

    

 

 

 

Shares used in non-GAAP calculation (midpoint of target range)

     157,000        157,000  

GAAP to Non-GAAP Reconciliation of Full Fiscal Year 2025 Targets

(in thousands, except per share amounts)

 

     Range for Fiscal Year Ending
October 31, 2025
 
     Low      High  

Target GAAP expenses

   $ 5,011,252      $ 5,068,252  

Adjustments:

     

Amortization of acquired intangible assets

     (46,000      (51,000

Stock-based compensation

     (820,000      (832,000

Acquisition/divestiture related items (1)

     (100,252      (100,252
  

 

 

    

 

 

 

Target non-GAAP expenses

   $ 4,045,000      $ 4,085,000  
  

 

 

    

 

 

 
     Range for Fiscal Year Ending
October 31, 2025
 
     Low      High  

Target GAAP earnings per diluted share attributed to Synopsys

   $ 10.14      $ 10.34  

Adjustments:

     

Amortization of acquired intangible assets

     0.32        0.29  

Stock-based compensation

     5.30        5.22  

Acquisition/divestiture related items (1)

     0.93        0.92  

Gain on sale of strategic investments

     0.02        0.02  

Tax adjustments

     (1.60      (1.60
  

 

 

    

 

 

 

Target non-GAAP earnings per diluted share attributed to Synopsys

   $ 15.11      $ 15.19  
  

 

 

    

 

 

 

Shares used in non-GAAP calculation (midpoint of target range)

     157,000        157,000  

 

(1)

Adjustments reflect actual expenses incurred by Synopsys as of April 30, 2025 or certain contractually obligated financing fees and related amortization expenses, and do not fully reflect all potential adjustments for future periods for the reasons set forth in “GAAP to Non-GAAP Reconciliation” below.

 

7


Forward-Looking Statements

This press release and the investor conference call contain forward-looking statements, including, but not limited to, statements regarding short-term and long-term financial targets, expectations and objectives including, among others, our long-term financial objectives, which include the anticipated effects of our pending acquisition of ANSYS, Inc. (the Ansys Merger); our products, technology and services; business and market outlook, opportunities, strategies and technological trends, such as artificial intelligence; the Ansys Merger, including, among other things, the anticipated timing of closing, the status of the related regulatory approvals, and its expected impact; planned dispositions and their expected impact; the potential impact of the uncertain macroeconomic environment on our financial results, including, but not limited to, the effects of sustained global inflationary pressures and elevated interest rates, potential economic slowdowns or recessions, supply chain disruptions, geopolitical pressures, including, among others, the unknown impact of current and future U.S. and foreign trade regulations, government actions and regulatory changes, such as export control restrictions and tariffs, and regional or global military conflicts, and fluctuations in foreign exchange rates, and associated global economic conditions; customer demand and market expansion; our planned product releases and capabilities; industry growth rates; the expected realization of our contracted but unsatisfied or partially unsatisfied performance obligations (backlog); software trends; planned stock repurchases; our expected tax rate; and the impact and result of pending legal, regulatory, administrative and tax proceedings. These statements involve risks, uncertainties and other factors that could cause our actual results, time frames or achievements to differ materially from those expressed or implied in such forward-looking statements. Such risks, uncertainties and factors include, but are not limited to: macroeconomic conditions and geopolitical uncertainty in the global economy; uncertainty in the growth of the semiconductor and electronics industries; the highly competitive industry we operate in; actions by the U.S.

 

8


or foreign governments, such as the imposition of additional export restrictions or tariffs; consolidation among our customers and our dependence on a relatively small number of large customers; risks and compliance obligations relating to the global nature of our operations; failure to complete the Ansys Merger on the terms described in our filings with the SEC, if at all; failure to obtain required governmental approvals related to the Ansys Merger or the imposition of conditions to such governmental approvals that may have an adverse effect on us; failure to realize the benefits expected from the Ansys Merger; and more. Additional information on potential risks, uncertainties and other factors that could affect Synopsys’ results is included in filings we make with the SEC from time to time, including in the sections entitled “Risk Factors” in our latest Annual Report on Form 10-K and in our latest Quarterly Report on Form 10-Q. The financial information contained in this press release should be read in conjunction with the consolidated financial statements and notes thereto included in Synopsys’ most recent reports on Forms 10-K and 10-Q, each as may be amended from time to time. Synopsys’ financial results for its second quarter of fiscal year 2025 are not necessarily indicative of Synopsys’ operating results for any future periods. The information provided herein is as of May 28, 2025. Synopsys undertakes no duty to, and does not intend to, update any forward-looking statement, whether as a result of new information, future events or otherwise, unless required by law.

SYNOPSYS, INC.

Unaudited Condensed Consolidated Statements of Income (1)

(in thousands, except per share amounts)

 

     Three Months Ended
April 30,
     Six Months Ended
April 30,
 
     2025      2024      2025      2024  

Revenue:

           

Time-based products

   $ 828,326      $ 781,714      $ 1,656,564      $ 1,586,777  

Upfront products

     510,676        396,389        878,800        838,755  
  

 

 

    

 

 

    

 

 

    

 

 

 

Total products revenue

     1,339,002        1,178,103        2,535,364        2,425,532  

Maintenance and service

     265,264        276,609        524,217        540,169  
  

 

 

    

 

 

    

 

 

    

 

 

 

Total revenue

     1,604,266        1,454,712        3,059,581        2,965,701  

Cost of revenue:

           

Products

     216,216        198,719        385,058        374,217  

Maintenance and service

     94,471        88,178        187,008        178,718  

 

9


Amortization of acquired intangible assets

     7,660       13,500       16,256       26,655  
  

 

 

   

 

 

   

 

 

   

 

 

 

Total cost of revenue

     318,347       300,397       588,322       579,590  
  

 

 

   

 

 

   

 

 

   

 

 

 

Gross margin

     1,285,919       1,154,315       2,471,259       2,386,111  

Operating expenses:

        

Research and development

     553,979       493,136       1,107,195       1,018,670  

Sales and marketing

     215,021       209,783       424,220       428,626  

General and administrative

     136,497       114,763       303,583       246,027  

Amortization of acquired intangible assets

     3,996       4,561       7,996       8,090  
  

 

 

   

 

 

   

 

 

   

 

 

 

Total operating expenses

     909,493       822,243       1,842,994       1,701,413  
  

 

 

   

 

 

   

 

 

   

 

 

 

Operating income

     376,426       332,072       628,265       684,698  

Interest expense

     (94,336     (7,067     (105,475     (8,805

Other income (expense), net

     114,101       16,525       164,518       123,091  
  

 

 

   

 

 

   

 

 

   

 

 

 

Income before income taxes

     396,191       341,530       687,308       798,984  

Provision (benefit) for income taxes

     47,181       45,437       40,887       68,346  
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income from continuing operations

     349,010       296,093       646,421       730,638  

Income (loss) from discontinued operations, net of income taxes

     (3,900     (7,004     (3,900     4,658  
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income

     345,110       289,089       642,521       735,296  

Less: Net income (loss) attributed to non-controlling interest and redeemable non-controlling interest

     (222     (3,018     1,506       (5,923
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income attributed to Synopsys

   $ 345,332     $ 292,107     $ 641,015     $ 741,219  
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income (loss) attributed to Synopsys

        

Continuing operations

   $ 349,232     $ 299,111     $ 644,915     $ 736,561  

Discontinued operations

     (3,900     (7,004     (3,900     4,658  
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income

   $ 345,332     $ 292,107     $ 641,015     $ 741,219  
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income (loss) per share attributed to Synopsys - basic:

        

Continuing operations

   $ 2.25     $ 1.96     $ 4.17     $ 4.83  

Discontinued operations

     (0.02     (0.05     (0.03     0.03  
  

 

 

   

 

 

   

 

 

   

 

 

 

Basic net income per share

   $ 2.23     $ 1.91     $ 4.14     $ 4.86  
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income (loss) per share attributed to Synopsys - diluted:

        

Continuing operations

   $ 2.24     $ 1.92     $ 4.13     $ 4.73  

Discontinued operations

     (0.03     (0.04     (0.03     0.03  
  

 

 

   

 

 

   

 

 

   

 

 

 

Diluted net income per share

   $ 2.21     $ 1.88     $ 4.10     $ 4.76  
  

 

 

   

 

 

   

 

 

   

 

 

 

Shares used in computing per share amounts:

        

Basic

     154,927       152,971       154,666       152,629  
  

 

 

   

 

 

   

 

 

   

 

 

 

Diluted

     156,088       155,770       156,218       155,610  
  

 

 

   

 

 

   

 

 

   

 

 

 

 

(1)

Synopsys’ second quarter of fiscal year 2025 and 2024 ended on April 30, 2025 and May 4, 2024, respectively. For presentation purposes, we refer to the closest calendar month end. Fiscal year 2024 was a 53-week year, which included an extra week in the first quarter.

 

10


SYNOPSYS, INC.

Unaudited Condensed Consolidated Balance Sheets (1)

(in thousands, except par value amounts)

 

     April 30, 2025      October 31, 2024  

ASSETS:

     

Current assets:

     

Cash and cash equivalents

   $ 14,119,095      $ 3,896,532  

Short-term investments

     144,816        153,869  
  

 

 

    

 

 

 

Total cash, cash equivalents and short-term investments

     14,263,911        4,050,401  

Accounts receivable, net

     1,002,195        934,470  

Inventories

     395,339        361,849  

Prepaid and other current assets

     1,217,584        1,122,946  
  

 

 

    

 

 

 

Total current assets

     16,879,029        6,469,666  

Property and equipment, net

     571,982        563,006  

Operating lease right-of-use assets, net

     585,704        565,917  

Goodwill

     3,461,272        3,448,850  

Intangible assets, net

     173,394        195,164  

Deferred income taxes

     1,509,159        1,247,258  

Other long-term assets

     575,977        583,700  
  

 

 

    

 

 

 

Total assets

   $ 23,756,517      $ 13,073,561  
  

 

 

    

 

 

 

LIABILITIES, REDEEMABLE NON-CONTROLLING INTEREST AND STOCKHOLDERS’ EQUITY:

     

Current liabilities:

     

Accounts payable and accrued liabilities

   $ 903,546      $ 1,163,592  

Operating lease liabilities

     104,170        94,791  

Deferred revenue

     1,375,398        1,391,737  

Short-term debt

     22,962        —   
  

 

 

    

 

 

 

Total current liabilities

     2,406,076        2,650,120  

Long-term operating lease liabilities

     587,438        574,065  

Long-term deferred revenue

     331,133        340,831  

Long-term debt

     10,027,681        15,601  

Other long-term liabilities

     488,584        469,738  
  

 

 

    

 

 

 

Total liabilities

     13,840,912        4,050,355  

Redeemable non-controlling interest

     —         30,000  

Stockholders’ equity:

     

Preferred stock, $0.01 par value: 2,000 shares authorized; none outstanding

     —         —   

Common stock, $0.01 par value: 400,000 shares authorized; 155,146 and 154,112 shares outstanding, respectively

     1,552        1,541  

 

11


Capital in excess of par value

     1,219,021       1,211,206  

Retained earnings

     9,624,282       8,984,105  

Treasury stock, at cost: 2,115 and 3,148 shares, respectively

     (689,001     (1,025,770

Accumulated other comprehensive income (loss)

     (240,136     (180,380
  

 

 

   

 

 

 

Total Synopsys stockholders’ equity

     9,915,718       8,990,702  

Non-controlling interest

     (113     2,504  
  

 

 

   

 

 

 

Total stockholders’ equity

     9,915,605       8,993,206  
  

 

 

   

 

 

 

Total liabilities, redeemable non-controlling interest and stockholders’ equity

   $ 23,756,517     $ 13,073,561  
  

 

 

   

 

 

 

 

(1)

Synopsys’ second quarter of fiscal year 2025 ended on April 30, 2025 and its fiscal year 2024 ended on November 2, 2024, respectively. For presentation purposes, we refer to the closest calendar month end. Fiscal year 2024 was a 53-week year, which included an extra week in the first quarter.

SYNOPSYS, INC.

Unaudited Condensed Consolidated Statements of Cash Flows (1)

(in thousands)

 

     Six Months Ended April 30,  
     2025     2024  

CASH FLOWS FROM OPERATING ACTIVITIES:

    

Net income

   $ 642,521     $ 735,296  

Adjustments to reconcile net income to net cash provided by operating activities:

    

Amortization and depreciation

     96,838       123,886  

Reduction of operating lease right-of-use assets

     51,728       48,179  

Amortization of capitalized costs to obtain revenue contracts

     25,405       37,912  

Stock-based compensation

     388,186       358,487  

Allowance for credit losses

     15,940       9,987  

(Gain) loss on sale of strategic investments

     2,435       (55,077

Gain on sale of building

     (51,385     —   

Loss on divestitures, net of transaction costs

     8,299       —   

Amortization of bridge financing costs

     40,411       7,085  

Amortization of debt issuance costs

     2,348       —   

Deferred income taxes

     (237,170     (170,854

Other

     (181     (2,607

Net changes in operating assets and liabilities, net of effects from acquisitions and dispositions:

    

Accounts receivable

     (74,098     20,889  

Inventories

     (39,766     (60,518

Prepaid and other current assets

     (140,472     (191,595

Other long-term assets

     (36,058     (104,551

Accounts payable and accrued liabilities

     (242,529     (142,086

Operating lease liabilities

     (48,617     (48,709

 

12


Income taxes

     (36,870     (229,536

Deferred revenue

     (37,412     52,612  

Unrealized loss on settlement of interest rate treasury lock

     (121,643     —   
  

 

 

   

 

 

 

Net cash provided by operating activities

     207,910       388,800  
  

 

 

   

 

 

 

CASH FLOWS FROM INVESTING ACTIVITIES:

    

Proceeds from maturities of short-term investments

     35,461       63,159  

Proceeds from sales of short-term investments

     22,015       —   

Purchases of short-term investments

     (47,558     (65,861

Proceeds from sales of strategic investments

     —        55,696  

Purchases of strategic investments

     (3,368     (860

Purchases of property and equipment, net

     (96,303     (78,763

Proceeds from sale of building

     74,279       —   

Acquisitions, net of cash acquired

     —        (139,557

Proceeds from business divestiture, net of cash divested

     70,082       —   

Other

     (611     —   
  

 

 

   

 

 

 

Net cash provided by (used in) investing activities

     53,997       (166,186
  

 

 

   

 

 

 

CASH FLOWS FROM FINANCING ACTIVITIES:

    

Proceeds from debt, net of issuance costs

     10,034,464       —   

Repayments on debt and credit facilities

     (1,289     (1,303

Payment of bridge financing and term loan costs

     —        (54,715

Issuances of common stock

     118,308       115,111  

Payments for taxes related to net share settlement of equity awards

     (166,872     (212,577

Redemption of redeemable non-controlling interest

     (30,000     —   

Other

     —        (1,096
  

 

 

   

 

 

 

Net cash provided by (used in) financing activities

     9,954,611       (154,580

Effect of exchange rate changes on cash, cash equivalents and restricted cash

     8,186       2,423  
  

 

 

   

 

 

 

Net change in cash, cash equivalents and restricted cash

     10,224,704       70,457  

Cash, cash equivalents and restricted cash, beginning of year, including cash from discontinued operations

     3,898,729       1,441,187  
  

 

 

   

 

 

 

Cash, cash equivalents and restricted cash, end of period, including cash from discontinued operations

     14,123,433       1,511,644  
  

 

 

   

 

 

 

Less: Cash, cash equivalents and restricted cash from discontinued operations

     —        6,445  
  

 

 

   

 

 

 

Cash, cash equivalents and restricted cash from continuing operations

   $ 14,123,433     $ 1,505,199  
  

 

 

   

 

 

 

 

(1)

Synopsys’ second quarter of fiscal year 2025 and 2024 ended on April 30, 2025 and May 4, 2024, respectively. For presentation purposes, we refer to the closest calendar month end. Fiscal year 2024 was a 53-week year, which included an extra week in the first quarter.

 

13


Synopsys provides segment information, namely revenue, adjusted segment operating income and adjusted segment operating margin, in accordance with Financial Accounting Standards Board Accounting Standards Codification Topic 280, Segment Reporting. Synopsys’ chief operating decision maker (“CODM”) is our Chief Executive Officer. In evaluating our business segments, the CODM considers the income and expenses that the CODM believes are directly related to those segments. The CODM does not allocate certain operating expenses managed at a consolidated level to our business segments and, as a result, the reported operating income and operating margin do not include these unallocated expenses as shown in the table below. These unallocated expenses are presented in the table below to provide a reconciliation of the total adjusted operating income from segments to our consolidated operating income from continuing operations:

SYNOPSYS, INC.

Business Segment Reporting (1)(2)

(in millions)

 

     Three Months Ended
April 30, 2025
    Three Months Ended
April 30, 2024
    Six Months Ended
April 30, 2025
    Six Months Ended
April 30, 2024
 

Revenue by segment

        

- Design Automation

   $ 1,122.3     $ 1,054.9     $ 2,142.5     $ 2,040.3  

% of Total

     70.0     72.5     70.0     68.8

- Design IP

   $ 482.0     $ 399.8     $ 917.1     $ 925.4  

% of Total

     30.0     27.5     30.0     31.2

Adjusted operating income by segment

        

- Design Automation

   $ 458.8     $ 418.2     $ 863.4     $ 777.7  

- Design IP

   $ 150.5     $ 124.8     $ 277.1     $ 370.5  

Adjusted operating margin by segment

        

- Design Automation

     40.9     39.6     40.3     38.1

- Design IP

     31.2     31.2     30.2     40.0

Total Adjusted Segment Operating Income Reconciliation (1)(2)

(in millions)

 

     Three Months Ended
April 30, 2025
     Three Months Ended
April 30, 2024
     Six Months Ended
April 30, 2025
     Six Months Ended
April 30, 2024
 

GAAP total operating income – as reported

   $ 376.4      $ 332.1      $ 628.3      $ 684.7  

Other expenses managed at consolidated level

           

-Amortization of acquired intangible assets(3)

     11.7        18.1        24.3        34.7  

-Stock-based compensation (3)

     201.7        162.7        388.2        328.2  

 

14


-Non-qualified deferred compensation plan

     (20.1      11.1        (0.5      50.5  

-Acquisition/divestiture related items (4)

     39.6        19.2        100.3        50.1  
  

 

 

    

 

 

    

 

 

    

 

 

 

Total adjusted segment operating income

   $ 609.3      $ 543.0      $ 1,140.5      $ 1,148.2  
  

 

 

    

 

 

    

 

 

    

 

 

 

 

(1)

Synopsys manages the business on a long-term, annual basis, and considers quarterly fluctuations of revenue and profitability as normal elements of our business. Amounts may not foot due to rounding.

(2)

Synopsys’ second quarter of fiscal year 2025 and 2024 ended on April 30, 2025 and May 4, 2024, respectively. For presentation purposes, we refer to the closest calendar month end. Fiscal year 2024 was a 53-week year, which included an extra week in the first quarter.

(3)

The adjustment includes non-GAAP expenses attributable to non-controlling interest and redeemable non-controlling interest.

(4)

The adjustment excludes the amortization of bridge financing costs entered into in connection with the pending Ansys Merger that was recorded in interest expense, and certain divestiture related items that were recorded in other income (expense), net in our unaudited condensed consolidated statements of income.

GAAP to Non-GAAP Reconciliation

Synopsys continues to provide all information required in accordance with GAAP but acknowledges evaluating its ongoing operating results may not be as useful if an investor is limited to reviewing only GAAP financial measures. Accordingly, Synopsys presents non-GAAP financial measures in reporting its financial results to provide investors with an additional tool to evaluate Synopsys’ operating results in a manner that focuses on what Synopsys believes to be its core business operations and what Synopsys uses to evaluate its business operations and for internal budgeting and resource allocation purposes. This press release includes non-GAAP earnings per diluted share, non-GAAP net income and non-GAAP tax rate for the periods presented. It also includes future estimates for non-GAAP expenses, non-GAAP interest and other income (expense), non-GAAP tax rate, non-GAAP earnings per diluted share and free cash flow. These non-GAAP financial measures may be different from non-GAAP financial measures used by other companies.

When possible, Synopsys provides a reconciliation of non-GAAP financial measures to their most closely applicable GAAP financial measures. Synopsys is unable to provide a full reconciliation of certain third quarter and full fiscal year 2025 non-GAAP financial targets to the corresponding GAAP financial measures on a forward-looking basis because Synopsys believes that it would not be possible for it to have the required information necessary to quantitatively reconcile such measures with sufficient precision without unreasonable efforts due to, among other things, the potential variability and limited predictability of the excluded adjustment items necessary for a full reconciliation such as certain acquisition/divestiture related items, restructuring charges, tax deduction variability, changes in the fair value of non-qualified deferred compensation plan, and gains (losses) on the sale of strategic investments. For the same reasons, Synopsys is unable to address the probable significance of the unavailable information.

 

15


Synopsys’ management does not itself, nor does it suggest that investors should, consider such non-GAAP financial measures in isolation from, as superior to, or as a substitute for, financial information prepared in accordance with GAAP. These non-GAAP financial measures are meant to supplement, and be viewed in conjunction with, the corresponding GAAP financial measures. Synopsys’ management believes presentation of non-GAAP financial measures, when shown in conjunction with the corresponding GAAP financial measures, provides useful information to investors allowing them to view financial and business trends relating to our financial condition and results of operations through the eyes of management. Synopsys’ management evaluates and makes decisions about our business operations using both GAAP financial measures and non-GAAP financial measures to help facilitate internal comparisons to Synopsys’ historical operating results and forecasted targets, planning and forecasting in subsequent periods and comparisons to competitors’ operating results.

The following are descriptions of the adjustments made to reconcile non-GAAP financial measures (other than free cash flow, which is defined in the footnote to the Financial Targets table above) to the most directly comparable GAAP financial measures:

(i) Amortization of acquired intangible assets. We incur expenses from amortization of acquired intangible assets, which may include impairment charges from write-downs of acquired intangible assets. Acquired intangible assets include, among other things, core/developed technology, customer relationships, contract rights, trademarks and trade names, and other intangibles related to acquisitions. We amortize the intangible assets over their estimated useful lives. We do not enter into acquisitions on a predictable cycle. The amount of an acquisition’s purchase price allocated to intangible assets and their estimated useful lives can vary significantly and are unique to each acquisition. From time to time, we incur impairment charges due to write-downs of acquired intangible assets. We believe that the presentation of non-GAAP financial measures that adjust for the amortization of intangible assets, including impairment charges, provides investors and others with a consistent basis for comparison across accounting periods.

 

16


We also exclude this item because such expenses are non-cash in nature and we believe the non-GAAP financial measures excluding this item provide meaningful supplemental information regarding our core operational performance and liquidity, and ability to invest in research and development and fund future acquisitions and capital expenditures.

(ii) Stock-based compensation. Stock-based compensation expenses consist primarily of expenses related to restricted stock units, stock options, employee stock purchase rights and other stock awards, including such expenses associated with acquisitions. We exclude stock-based compensation expense from our non-GAAP financial measures primarily because it is not an expense that typically requires or will require cash settlement by us. Further, the expense for the fair value of the stock-based instruments we utilize may bear little resemblance to the actual value realized upon the vesting or future exercise of the related stock-based awards and, therefore, is not used by management to assess the core profitability of our business operations.

(iii) Acquisition/divestiture related items. In connection with certain of our business combinations and/or divestitures, we incur significant expenses that we would not have otherwise incurred as part of our business operations. These expenses include, among other things, compensation expenses, professional fees and other direct expenses, concurrent restructuring activities and divestiture activities, including employee severance and other exit costs, bridge financing costs, costs related to integration activities, debt forgiveness, changes to the fair value of contingent consideration related to the acquired company, and amortization of the fair value difference of below-market value assets arising from arrangements entered into or acquired in conjunction with an acquisition. We also recognize the gains and losses from the mark-up of equity or cost method investments to fair value upon obtaining control through acquisition. We exclude these items because they are related to acquisitions and divestitures and have no direct correlation to the core operation of our business. Further, because we do not acquire or divest businesses on a predictable cycle and the terms of each transaction can vary significantly and are unique to each transaction, we believe it is useful to exclude such expenses when looking for a consistent basis for comparison across accounting periods.

 

17


(iv) Restructuring charges. We initiate restructuring activities to align our costs to our operating plans and business strategies based on then-current economic conditions, and such activities have a specific and defined term. Restructuring costs generally include severance and other termination benefits related to voluntary retirement programs, involuntary headcount reductions and facilities closures. Such restructuring costs include elimination of operational redundancy, permanent reductions in workforce and facilities closures and, therefore, are not considered by us to be a part of the core operation of our business and are not used by management when assessing the core profitability and performance of our business operations.

(v) Gains (losses) on the sale of strategic investments. We exclude gains and losses on the sale of equity investments in privately held companies because we do not believe they are reflective of our core business and operating results.

(vi) Deferred compensation. We exclude changes in the fair value of our non-qualified deferred compensation plan because we do not use these to assess the core profitability of our business operations.

(vii) Income tax effect of non-GAAP pre-tax adjustments. Excluding the income tax effect of non-GAAP pre-tax adjustments from the provision for income taxes assists investors in understanding the tax provision associated with those adjustments and the effect on net income. We utilize an annual non-GAAP tax rate in calculating non-GAAP financial measures to provide better consistency across interim reporting periods by eliminating the effects of certain non-recurring and other period-specific items, which can vary in size and frequency and do not necessarily reflect our normal operations, and to more closely align our tax rate with our expected geographic earnings mix. This annual non-GAAP tax rate is based on an evaluation of our historical and projected mix of U.S. and international profit before tax, taking into account the impact of non-GAAP adjustments, U.S. tax law changes, as well as other factors such as our current tax structure, existing tax positions and expected recurring tax incentives. Based on these considerations, we have elected to adopt a non-GAAP tax rate of 16% for fiscal year 2025.

 

18


About Synopsys

Catalyzing the era of pervasive intelligence, Synopsys, Inc. (Nasdaq: SNPS) delivers trusted and comprehensive silicon to systems design solutions, from electronic design automation to silicon IP and system verification and validation. We partner closely with semiconductor and systems customers across a wide range of industries to maximize their R&D capability and productivity, powering innovation today that ignites the ingenuity of tomorrow. Learn more at www.synopsys.com.

© 2025 Synopsys, Inc. All rights reserved. Synopsys, the Synopsys logo, and other Synopsys trademarks are available at https://www.synopsys.com/company/legal/trademarks-brands.html. Other company or product names may be trademarks of their respective owners.

 

19